title: Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity.
abstract: Ghrelin is a hormone that is involved in the regulation of food intake. Neuronal, endocrine, and genetic factors have been shown to regulate plasma ghrelin levels; but the determinants of fasting ghrelin concentrations are not yet fully understood. The main aim was to explore the roles of adiposity and genetic differences in determining fasting plasma total ghrelin levels. We measured total ghrelin levels in a population of 23 monozygotic twin pairs discordant for obesity. In addition, 2 variants of ghrelin gene, namely, Arg51Gln and Leu72Met, were genotyped in 3 populations of monozygotic twin pairs: 23 obesity-discordant, 43 lean-concordant, and 46 obesity-concordant twin pairs. In discordant twins, lean co-twins had higher fasting plasma total ghrelin levels (950 pg/mL, SD = 328 pg/mL) than obese twins (720 pg/mL, SD = 143 pg/mL; P = .003). Arg51Gln-polymorphism of the ghrelin gene was equally distributed between the twin groups. However, there were significant differences in genotype frequencies at the Leu72Met polymorphism between the discordant and obese-concordant groups (P = .003) and between the discordant and lean-concordant groups (P = .011), but not between the 2 concordant groups. In the discordant group, there were fewer Met carriers (4%) than among the obese (17%) or the lean-concordant groups (15%). Plasma total ghrelin levels are affected by acquired obesity independent of genetic background. The Leu72 allele is particularly common among monozygotic twins discordant for obesity, suggesting that this ghrelin allele is more permissive in the regulation of energy balance. The ghrelin gene may thus play a role in the regulation of variability of body weight, such that Leu72 allele carriers are more prone to weight variability in response to environmental factors.
authors.affiliation: Department of Internal Medicine and Biocenter Oulu, Clinical Research Center Oulu, University of Oulu, Oulu University Hospital, P.O. Box 5000, FIN-90014, Finland.
authors.forename: Piia
authors.initials: P
authors.lastname: Leskelä
authors.forename: Olavi
authors.initials: O
authors.lastname: Ukkola
authors.forename: Johanna
authors.initials: J
authors.lastname: Vartiainen
authors.forename: Tapani
authors.initials: T
authors.lastname: Rönnemaa
authors.forename: Jaakko
authors.initials: J
authors.lastname: Kaprio
authors.forename: Claude
authors.initials: C
authors.lastname: Bouchard
authors.forename: Y Antero
authors.initials: YA
authors.lastname: Kesäniemi
mesh_terms: D000328:Adult; D001835:Body Weight / Q000235:genetics*; D004734:Energy Metabolism / Q000235:genetics; D005215:Fasting; D005260:Female; D005787:Gene Frequency; D014644:Genetic Variation; D005838:Genotype; D054439:Ghrelin / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000235:genetics* / Q000378:metabolism*; D011110:Polymorphism, Genetic; D014430:Twins, Monozygotic / Q000097:blood / Q000235:genetics*
chemical_list: D054439:Ghrelin